This is an international, one day and a half workshop in which international experts will present the hot topics
in the management of aging people. One European meeting in Barcelona and a second meeting in Buenos
Aires during 2017, will be held.
FIRST DAY: 24th November (Pau Gil Auditorium)
Aging in HIV disease
Chairman: Pedro Cahn and Bonaventura Clotet
Increased and accelerated age-related complications in HIV-infected patients.
Polypharmacy and drug-drug interactions.
The effects of age and HIV on neuropsychological performance
Switching antiretroviral therapy to safer strategies based on integrase inhibitors.
Overview of our HIV aging population: Current and future requirements.
Chairman: Peter Reiss
Results from questionnaires. Objective: Previously to the Workshop a questionnaire will be collected from patients aged 55 years or over of different centres to identify the needs of this population. Data will be presented and discussed among the participants in this round table.
Han Nefkens (Community representative) Jose Antonio Serra (Geriatrician) Giovanni Guaraldi David Back
Poster discussion and Dinner (Sala Hipòstila)
Abstracts: Oral presentations. Objective: The 2 best abstracts will be presented (5 minutes for presentation + 5 minutes for questions). Each will receive a prize, first 1000€ and the second 500€. The remaining accepted abstracts will be discussed as a poster during the dinner time.
SECOND DAY: 25th November (Pau Gil Auditorium)
Basis of accelerated aging in HIV-infected patients
Chairman: Bonaventura Clotet
Accelerated immune senescence and inflammaging
The microrobiome in HIV, inflammation and aging
The gut microbiome in frail and non-frail elders
HIV and frailty: what we know and future directions
Chairman: José Antonio Serra
Frailty, aging and HIV
Management of HIV drug resistance in the aging subjects.
Chairman: Roger Paredes
Management of HIV resistance in HIV aging patients. Switching to the most suitable regimen.
New approach to HCV
Chairman: Cristina Tural
Strategies for the cure of chronic and acute hepatitis C infection in HIV coinfected subjects. And after the cure?
Overview of our HIV aging population: New proposals. Closing remarks.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.